Advantage AxisDirect



ABOUT THE ISSUER


Eris Lifesciences Limited (“Eris”) is in developing, manufacturing and commercializing branded pharmaceutical products. Eris specializes in select therapeutic areas within the chronic and acute categories of the indian pharmaceutical market, such as: cardiovascular, anti-diabetics, vitamins, gastroenterology, and anti-infectives. Company’s focus has been on developing, manufacturing and marketing products, which are linked to lifestyle related disorders, that are chronic in nature, and to a target population which primarily consults specialists and superspecialists.

 


ISSUE DETAILS



  • Price Band

    Rs. 600 - Rs.603

  • Bid Lot

    24 Shares and in multiple thereof

  • Issue period

    June 16 - 20, 2017

Invest now    Prospectus  


STEPS


  • Step 1

    Log in to your AxisDirect account

  • Step 2

    Under Trading tab, click on IPO/OFS section

  • Step 3

    Click on “Current IPO/FD/OFS” tab

  • Step 4

    Select ‘‘Eris Lifesciences Limited’’ & click “apply”


Investment Options
Platforms
Markets
Learn
Insights
Important Links
Axis Group

Main Office Address

Unit No. 2, Phoenix Market City,15, LBS Road, Near Kamani Junction, Kurla (West), Mumbai- 400 070.

Telephone Numbers

1800-210-0808

022-61480808

Customer care Timings

Mon- Fri: 08.45 to 17.30 IST

1st, 3rd and 5th Sat: 10.00 to 13.00 IST

Email Address

In case of any queries please write to: helpdesk@axisdirect.in

Hide

Mutual Fund Investments are subject to market risks, read all scheme related documents carefully. ASL is a distributor of Mutual Funds, IPOs and Bonds.
Investments in securities market are subject to market risks. Read all the related documents carefully before investing.
AxisDirect is a brand under which Axis Securities Limited offers its retail broking and investment services.Trading Member| Axis Securities Limited,CINNo.U74992MH2006PLC163204 | NSE SEBI Registration Number: INB/INF/INE 231481632 | BSE SEBI Registration Number INB/INF 011481638 | MSEI SEBI Registration Number: INB/INF/INE 261481635 | ARN- 64610 CDSL-IN-DP-CDSL-693-2013 SEBI-Research Analyst Reg. No. INH 000000297
In case of any grievances please write to: customer.grievance@axisdirect.in

Attention AxisDirect Investors
  • Contact details: To prevent unauthorised transactions in your account, kindly update your mobile numbers/email IDs with your stock broker, M/S Axis Securities.Know More
  • KYC Notification: KYC is one time exercise while dealing in securities markets- once KYC is done through a SEBI registered intermediary..... Know More
  • Advisory against Tips:Investors are advised not to blindly follow the unfounded rumours, Tips given in social networks, SMS, WhatsApp, Blogs etc. and invest Know More
  • IPO Investment: No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise Know More
  • Client Registration Documents:Client Registration Documents are now available in Vernacular Language on NSE website.Know More

2015 Axis Direct All rights reserved.

v2.0.42-S41